Prophylaxis against opportunistic infections in persons infected with human immunodeficiency virus

American Journal of the Medical Sciences

Volumn 328, Issue 1, 2004, Pages 64-69

  Martin, Jane E ^a,b   Besch, C Lynn ^a  

^a LOUISIANA STATE UNIVERSITY HEALTH SCIENCES CENTER   (United States)

^b NONE   (United States)

Author keywords

AIDS; Human immunodeficiency virus; Opportunistic infections; Prophylaxis

Indexed keywords

AMANTADINE; ATOVAQUONE; AZITHROMYCIN; CLARITHROMYCIN; COTRIMOXAZOLE; DAPSONE; FLUCONAZOLE; FOLINIC ACID; GANCICLOVIR; HEPATITIS A VACCINE; HERPES ZOSTER IMMUNOGLOBULIN; INACTIVATED VACCINE; ISONIAZID; ITRACONAZOLE; OSELTAMIVIR; PENTAMIDINE; PNEUMOCOCCUS VACCINE; PYRAZINAMIDE; PYRIDOXINE; PYRIMETHAMINE; RECOMBINANT HEPATITIS B VACCINE; RIFABUTIN; RIFAMPICIN; RIMANTADINE;

ADOLESCENT; ADULT; COCCIDIOIDES IMMITIS; COCCIDIOIDOMYCOSIS; CRYPTOCOCCOSIS; CRYPTOCOCCUS NEOFORMANS; CYTOMEGALOVIRUS; CYTOMEGALOVIRUS INFECTION; HEPATITIS A; HEPATITIS A VIRUS; HEPATITIS B; HEPATITIS B VIRUS; HERPES ZOSTER; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HISTOPLASMA CAPSULATUM; HISTOPLASMOSIS; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INFECTION PREVENTION; INFLUENZA; INFLUENZA VIRUS; MEDICAL SOCIETY; MYCOBACTERIOSIS; MYCOBACTERIUM AVIUM; MYCOBACTERIUM TUBERCULOSIS; NONHUMAN; OPPORTUNISTIC INFECTION; PNEUMOCYSTIS CARINII; PNEUMOCYSTOSIS; PNEUMONIA; PRACTICE GUIDELINE; PRIMARY PREVENTION; PUBLIC HEALTH SERVICE; PUBLICATION; REVIEW; SECONDARY PREVENTION; STREPTOCOCCUS PNEUMONIAE; TOXOPLASMA GONDII; TOXOPLASMOSIS; VARICELLA ZOSTER VIRUS;

EID: 3242720543     PISSN: 00029629     EISSN: None     Source Type: Journal    
DOI: 10.1097/00000441-200407000-00009     Document Type: Article

References (7)

1. Centers for Disease Control and Prevention. Guidelines for preventing opportunistic infections among HIV-infected persons-2002. Recommendations of the U. S. Public Health Service and the Infectious Diseases Society of America. MMWR Recomm Rep 2002;51(No. RR-8):1-52.
2. Centers for Disease Control and Prevention. Report of the NIH Panel to define principles of therapy of HIV infection and guidelines for use of antiretroviral agents in HIV-infected adults and adolescents. MMWR Recomm Rep 1998;47(No. RR-5):1-82.
3. Centers for Disease Control and Prevention. Updated guidelines for the use of rifabutin or rifampin for the treatment and prevention of tuberculosis among HIV-infected patients taking protease inhibitors or nonnucleoside reverse transcriptase inhibitors. MMWR Morb Mortal Wkly Rep 2000;49:185-9.
4. Centers for Disease Control and Prevention. Prevention and control of influenza: recommendations of the advisory committee on immunization practices (ACIP). MMWR Recomm Rep 2003;52(No. RR-08):1-36. [erratum in MMWR Morb Mortal Wkly Rep 2003;52:526.]
5. Centers for Disease Control and Prevention. Prevention and control of influenza: recommendations of the advisory committee on immunization practices (ACIP). MMWR Recomm Rep 2003;52(No. RR-08):1-36. [erratum in MMWR Morb Mortal Wkly Rep 2003;52:526.]
6. Centers for Disease Control and Prevention. Hepatitis B virus: a comprehensive strategy for eliminating transmission in the United States through universal childhood vaccination. Recommendations of the Immunization Practices Advisory Committee (ACIP). MMWR Recomm. Rep 1991;40(RR-13):1-25.
7. Watts DH. Drug therapy: management of human immunodeficiency virus infection in pregnancy. N Engl J Med 2002;346: 1879-91.